| Summary of Restatements And Reclassifications of Quaterly Report |
|
|
|
|
|
|
|
|
|
|
|
|
|
October 1,
2022 |
|
|
|
(Unaudited) |
|
|
|
(As restated) |
|
|
|
Previously Reported |
|
Effect of Restatement |
|
(Unaudited) |
|
Consolidated balance sheets as of October 1, 2022 |
|
|
|
|
|
|
|
Note receivable, net |
|
|
11,345 |
|
|
(1,720 |
) |
|
9,625 |
|
Total assets |
|
$ |
31,304 |
|
$ |
(1,720 |
) |
$ |
29,584 |
|
Total liabilities |
|
|
30,159 |
|
|
— |
|
|
30,159 |
|
Additional paid-in capital |
|
|
45,747 |
|
|
— |
|
|
45,747 |
|
Accumulated deficit |
|
|
(43,988 |
) |
|
(1,720 |
) |
|
(45,708 |
) |
Total stockholders' equity (deficit) |
|
|
1,145 |
|
|
(1,720 |
) |
|
(575 |
) |
Total liabilities and stockholders' equity (deficit) |
|
$ |
31,304 |
|
$ |
(1,720 |
) |
$ |
29,584 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Thirteen Weeks Ended |
|
|
For the Thirty-Nine Weeks Ended |
|
|
|
October 1,
2022 |
|
|
October 1,
2022 |
|
|
|
Previously Reported |
|
Effect of Restatement |
|
(As restated) |
|
|
Previously Reported |
|
Effect of Restatement |
|
(As restated) |
|
Selling, general and administrative expenses |
|
|
2,858 |
|
|
— |
|
|
2,858 |
|
|
|
8,711 |
|
|
(6 |
) |
|
8,705 |
|
Gain on sale of GeoTraq |
|
|
— |
|
|
— |
|
|
— |
|
|
|
(12,091 |
) |
|
12,091 |
|
|
— |
|
Operating income (loss) |
|
|
(1,824 |
) |
|
— |
|
|
(1,824 |
) |
|
|
7,916 |
|
|
(12,085 |
) |
|
(4,169 |
) |
Interest income (expense), net |
|
|
36 |
|
|
94 |
|
|
130 |
|
|
|
(254 |
) |
|
131 |
|
|
(123 |
) |
Total other income (expense), net |
|
|
(234 |
) |
|
94 |
|
|
(140 |
) |
|
|
1,931 |
|
|
131 |
|
|
2,062 |
|
Income (loss) from continuing operations before provision for income taxes |
|
|
(2,058 |
) |
|
94 |
|
|
(1,964 |
) |
|
|
9,847 |
|
|
(11,954 |
) |
|
(2,107 |
) |
Net income (loss) from continuing operations |
|
|
(2,074 |
) |
|
94 |
|
|
(1,980 |
) |
|
|
9,824 |
|
|
(11,954 |
) |
|
(2,130 |
) |
Net income from discontinued operations, net of tax |
|
|
— |
|
|
(1 |
) |
|
(1 |
) |
|
|
— |
|
|
10,234 |
|
|
10,234 |
|
Net income (loss) |
|
$ |
(2,074 |
) |
$ |
93 |
|
$ |
(1,981 |
) |
|
$ |
9,824 |
|
$ |
(1,720 |
) |
$ |
8,104 |
|
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted income (loss) per share from continuing operations |
|
$ |
(0.66 |
) |
$ |
0.03 |
|
$ |
(0.63 |
) |
|
$ |
3.12 |
|
$ |
(3.80 |
) |
$ |
(0.68 |
) |
Basic income per share from discontinued operations |
|
$ |
— |
|
$ |
(0.00 |
) |
$ |
(0.00 |
) |
|
$ |
— |
|
$ |
3.25 |
|
$ |
3.25 |
|
Diluted income per share from discontinued operations |
|
$ |
— |
|
$ |
(0.00 |
) |
$ |
(0.00 |
) |
|
$ |
— |
|
$ |
2.93 |
|
$ |
2.93 |
|
Basic income (loss) per share |
|
$ |
(0.66 |
) |
$ |
0.03 |
|
$ |
(0.63 |
) |
|
$ |
3.12 |
|
$ |
(0.55 |
) |
$ |
2.57 |
|
Diluted income (loss) per share |
|
$ |
(0.66 |
) |
$ |
0.03 |
|
$ |
(0.63 |
) |
|
$ |
2.81 |
|
$ |
(0.49 |
) |
$ |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Thirty-Nine Weeks Ended |
|
|
|
October 1, 2022 |
|
|
|
Previously Reported |
|
Effect of Restatement |
|
As restated |
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
9,824 |
|
|
(1,720 |
) |
$ |
8,104 |
|
Accretion of note receivable discount |
|
|
(95 |
) |
|
(130 |
) |
|
(225 |
) |
Gain on sale of GeoTraq |
|
|
(12,091 |
) |
|
1,850 |
|
|
(10,241 |
) |
Net cash used in operating activities |
|
|
(2,391 |
) |
|
— |
|
|
(2,391 |
) |
|